NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»12/04/2010 [Industry news]
Radient Pharmaceuticals Monetizing China-Based Jade Pharmaceutical

US-based pharmaceutical company Radient Pharmaceuticals Corporation announced today it anticipates prospective purchasers or financiers will complete due diligence for RPC\'s China-based subsidiary Jade Pharmaceutical, Inc. by the end of May 2010.

 
US-based pharmaceutical company Radient Pharmaceuticals Corporation announced today it anticipates prospective purchasers or financiers will complete due diligence for RPC\'s China-based subsidiary Jade Pharmaceutical, Inc. by the end of May 2010. RPC expects JPI will be contractually positioned to move forward with the completion of a sale or financing by the end of the third quarter 2010. RPC currently owns approximately 98% of JPI, which as part of RPC\'s deconsolidation process, is noted as a special asset on RPC\'s balance sheet and valued at approximately US$20 million as of September 30, 2009. According to Douglas MacLellan, Chairman and CEO of Radient Pharmaceuticals Corporation, \"We are extremely pleased to move down an orderly path to maximize the monetization of our China-based asset. This is in accordance with our original deconsolidation plan and is in the best interest of the company, our subsidiary and RPC shareholders.\" For additional information on Radient Pharmaceuticals or JPI visit the Company\'s corporate website at www.Radient-Pharma.com. For Investor Relations information contact Ms. Kristine Szarkowitz at kszarkowitz@Radient-Pharma.com or 1.206.310.5323. About Radient Pharmaceuticals: Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is an integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, and premium skin care products.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.